1261MO Updated results from a phase I/II study of mobocertinib (TAK-788) in NSCLC with EGFR exon 20 insertions (exon20ins)

Greg J. Riely, Joel W. Neal, D. Ross Camidge, Alexander I. Spira, Zofia Piotrowska, Leora Horn, Daniel B. Costa, Anne S. Tsao, Jay Patel, Shirish M. Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, Howard West, Tarek Mekhail, Ryan D. Gentzler, D. Nguyen, Veronica Bunn, Shu Jin, Zhichun Feng, Pasi A. Jänne